Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

HBV Reactivation in Patients Treated with Antitumor Necrosis Factor-Alpha (TNF-α) Agents for Rheumatic and Dermatologic Conditions: A Systematic Review and Meta-Analysis.

Cantini F, Boccia S, Goletti D, Iannone F, Leoncini E, Panic N, Prignano F, Gaeta GB.

Int J Rheumatol. 2014;2014:926836. doi: 10.1155/2014/926836. Epub 2014 Jul 7. Review.

PMID:
25114684
[PubMed]
Free PMC Article
2.

Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, Pinnetti C, Sampaolesi A, Antinori A, Girardi E, Goletti D.

J Infect. 2014 Jun 26. pii: S0163-4453(14)00187-X. doi: 10.1016/j.jinf.2014.06.009. [Epub ahead of print]

PMID:
24975174
[PubMed - as supplied by publisher]
3.

A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2014 May 5;9(5):e96367. doi: 10.1371/journal.pone.0096367. eCollection 2014.

PMID:
24797271
[PubMed - in process]
Free PMC Article
4.

Restarting biologics and management of patients with flares of inflammatory rheumatic disorders or psoriasis during active tuberculosis treatment.

Cantini F, Prignano F, Goletti D.

J Rheumatol Suppl. 2014 May;91:78-82. doi: 10.3899/jrheum.140106.

PMID:
24789004
[PubMed - in process]
5.
6.

Adalimumab, etanercept, infliximab, and the risk of tuberculosis: data from clinical trials, national registries, and postmarketing surveillance.

Cantini F, Niccoli L, Goletti D.

J Rheumatol Suppl. 2014 May;91:47-55. doi: 10.3899/jrheum.140102.

PMID:
24789000
[PubMed - in process]
7.

Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.

Goletti D, Sanduzzi A, Delogu G.

J Rheumatol Suppl. 2014 May;91:24-31. doi: 10.3899/jrheum.140099.

PMID:
24788997
[PubMed - in process]
8.

The spectrum of tuberculosis infection: new perspectives in the era of biologics.

Delogu G, Goletti D.

J Rheumatol Suppl. 2014 May;91:11-6. doi: 10.3899/jrheum.140097.

PMID:
24788995
[PubMed - in process]
9.

Biologics and tuberculosis risk: the rise and fall of an old disease and its new resurgence.

Cantini F, Goletti D.

J Rheumatol Suppl. 2014 May;91:1-3. doi: 10.3899/jrheum.140095. No abstract available.

PMID:
24788993
[PubMed - in process]
10.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

PMID:
24659544
[PubMed - in process]
Free PMC Article
11.

High urine IP-10 levels associate with chronic HCV infection.

Petrone L, Chiacchio T, Vanini V, Petruccioli E, Cuzzi G, Di Giacomo C, Pucci L, Montalbano M, Lionetti R, Testa A, Lapa D, Navarra A, Visco-Comandini U, Goletti D.

J Infect. 2014 Jun;68(6):591-600. doi: 10.1016/j.jinf.2014.02.008. Epub 2014 Feb 26.

PMID:
24582930
[PubMed - in process]
12.

miRNA signatures in Sera of patients with active pulmonary tuberculosis.

Miotto P, Mwangoka G, Valente IC, Norbis L, Sotgiu G, Bosu R, Ambrosi A, Codecasa LR, Goletti D, Matteelli A, Ntinginya EN, Aloi F, Heinrich N, Reither K, Cirillo DM.

PLoS One. 2013 Nov 21;8(11):e80149. doi: 10.1371/journal.pone.0080149. eCollection 2013.

PMID:
24278252
[PubMed - in process]
Free PMC Article
13.

TBNET - Collaborative research on tuberculosis in Europe.

Giehl C, Lange C, Duarte R, Bothamley G, Gerlach C, Cirillo DM, Wagner D, Kampmann B, Goletti D, Juers T, Sester M.

Eur J Microbiol Immunol (Bp). 2012 Dec;2(4):264-74. doi: 10.1556/EuJMI.2.2012.4.4. Epub 2012 Dec 11.

PMID:
24265908
[PubMed]
Free PMC Article
14.

Cystic echinococcosis in a single tertiary care center in Rome, Italy.

Petrone L, Cuzzi G, Colace L, Ettorre GM, Busi-Rizzi E, Schininà V, Pucillo L, Angeletti C, Pane S, Di Caro A, Bordi E, Girardi E, Pozio E, Corpolongo A, Teggi A, Brunetti E, Goletti D.

Biomed Res Int. 2013;2013:978146. doi: 10.1155/2013/978146. Epub 2013 Sep 14.

PMID:
24151631
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment.

Dorhoi A, Iannaccone M, Farinacci M, Faé KC, Schreiber J, Moura-Alves P, Nouailles G, Mollenkopf HJ, Oberbeck-Müller D, Jörg S, Heinemann E, Hahnke K, Löwe D, Del Nonno F, Goletti D, Capparelli R, Kaufmann SH.

J Clin Invest. 2013 Nov 1;123(11):4836-48.

PMID:
24084739
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis.

Lagrange PH, Thangaraj SK, Dayal R, Deshpande A, Ganguly NK, Girardi E, Joshi B, Katoch K, Katoch VM, Kumar M, Lakshmi V, Leportier M, Longuet C, Malladi SV, Mukerjee D, Nair D, Raja A, Raman B, Rodrigues C, Sharma P, Singh A, Singh S, Sodha A, Kabeer BS, Vernet G, Goletti D.

PLoS One. 2013 Sep 6;8(9):e73579. doi: 10.1371/journal.pone.0073579. eCollection 2013.

PMID:
24039990
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis.

Petruccioli E, Petrone L, Vanini V, Sampaolesi A, Gualano G, Girardi E, Palmieri F, Goletti D.

J Infect. 2013 Jun;66(6):475-86. doi: 10.1016/j.jinf.2013.02.004. Epub 2013 Feb 24.

PMID:
23462597
[PubMed - indexed for MEDLINE]
18.

Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.

Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, Lazor-Blanchet C, Petruccioli E, Hanekom W, Goletti D, Bart PA, Nicod L, Pantaleo G, Harari A.

Eur J Immunol. 2013 Jun;43(6):1568-77. doi: 10.1002/eji.201243262.

PMID:
23456989
[PubMed - indexed for MEDLINE]
19.

Autophagy in Mycobacterium tuberculosis infection: a passepartout to flush the intruder out?

Goletti D, Petruccioli E, Romagnoli A, Piacentini M, Fimia GM.

Cytokine Growth Factor Rev. 2013 Aug;24(4):335-43. doi: 10.1016/j.cytogfr.2013.01.002. Epub 2013 Feb 8. Review.

PMID:
23395260
[PubMed - indexed for MEDLINE]
20.

Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment.

Bartalesi F, Goletti D, Spinicci M, Cavallo A, Attala L, Mencarini J, Fiori G, Li Gobbi F, Mantella A, Benucci M, Prignano F, Pimpinelli N, Matucci Cerinic M, Girardi E, Bartoloni A.

J Infect. 2013 Apr;66(4):346-56. doi: 10.1016/j.jinf.2012.10.017. Epub 2012 Oct 24.

PMID:
23103667
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk